Nereus Pharmaceuticals Inc., of San Diego, appointed Andrew Dorr chief medical officer and senior vice president of clinical development and regulatory affairs

Amylin Pharmaceuticals Inc., of La Jolla, Calif., said its president and CEO, Ginger Graham, was elected to the California Healthcare Institute's board...Angiotech Pharmaceuticals Inc., of Vancouver, British Columbia, appointed Gary Ingenito senior vice president, clinical development and regulatory affairs...HTG Inc., of Tucson, Ariz., appointed Daniel Von Hoff and Raymond Woosley to its scientific advisory board

Neurotech, of Lincoln, R.I., appointed Al Reaves vice president of clinical development...Pharming Group NV, of Leiden, the Netherlands, appointed Ron van Amsterdam director clinical development, and Lilian Tijburg director quality assurance

Aegera Therapeutics Inc., of Montreal, appointed William Peters and Lennie Ryer to its board...Avera Pharmaceuticals Inc., of Irvine, Calif., appointed Jeffrey McKelvy president and CEO...Members are Timothy Henry, Robert Simari and Byron Williams

Biophage Pharma , of Montreal, appointed Richard Sherman chairman and Bruce Schmidt chief business officer...Cortex Pharmaceuticals Inc. , of Irvine, Calif., appointed Harry Mansbach chief medical officer and vice president of clinical development

Novagali Pharma, of Evry, France, appointed Jerome Martinez chairman and Alain Munoz president of the supervisory board...Rosalind Franklin University of Medicine and Science in North Chicago, Ill., elected Ruth Rothstein as chair of its board...VistaGen Therapeutics Inc., of Burlingame, Calif., appointed Lynda Sutton director and vice president, regulatory affairs, and Shawn Singh chief operating officer and general counsel

Cortex Pharmaceuticals Inc., of Irvine, Calif., appointed Harry Mansbach chief medical officer and vice president, clinical development...Merix Bioscience Inc., of Durham, N.C., appointed Lothar Finke vice president of clinical development, Doug Winship vice president of quality and regulatory affairs, and Michel Greco and Richard Meadows to its board

and Jinsam You, Tony Tegeler and Dariusz Janecki to its scientific team...and Howard Simon senior vice president of human resources and associated general counsel

BioEnterprise Corp., of Cleveland, appointed Glen Gaughan and Michael Lang to its business development team...Chromos Molecular Systems Inc., of Burnaby, British Columbia, appointed Phillip Maples vice president of clinical development and manufacturing, Alan Hardwick vice president of process development and Kathryn Hayashi vice president of finance

SinusPharma Inc., of Carpinteria, Calif., appointed Robin Campbell president, CEO and a member of its board...It also appointed John McCarthy senior vice president of corporate development and chief financial officer, and Jeremy Chadwick vice president of program management...Viral Genetics, of Azusa, Calif., appointed Eric Rosenberg to its scientific and medical advisory board

Inspire Pharmaceuticals Inc., of Durham, N.C., appointed Richard Kent and re-elected Christy Shaffer to its board...Nanogen Inc., of San Diego, appointed David Ludvigson president and chief operating officer...Procyon Biopharma Inc., of Montreal, appointed Jinzi Wu vice president of preclinical and basic research

Christine Dingivan to vice president of clinical development, head of strategic operations...and Peter Young to vice president of information technology

Orexo AB, of Uppsala, Sweden, appointed Zsolt Lavotha president and CEO...Rinat Neuroscience Corp., of Palo Alto, Calif., appointed David Pritchard chief business officer and Patricia Ann Walicke vice president of clinical development

The Pittsburgh Life Sciences Greenhouse appointed Grainne McClorey executive assistant, and promoted David Palmer to chief operating officer, Reed McManigle to director of investment programs and incubation services and Pamela Bush to investment programs manager

ActivBiotics Inc., of Lexington, Mass., appointed Andrew Sternlicht vice president of clinical development...It also promoted Bruce Sargent to vice president of discovery research and development, Patricia Ellis to vice president of quality and regulatory affairs and Barbara Galbiati to director of analytical quality services

Affymax Inc., of Palo Alto, Calif., appointed Douglas Cole vice president of development and Julie Iwashita director of clinical development...AVI BioPharma Inc., of Portland, Ore., appointed Peter O'Hanley senior vice president of clinical development and regulatory affairs and Ray Cummings vice president of business development

Pacific Growth Equities, of San Francisco, promoted Thomas Dietz and Stephen Massocca to co-CEOs...Rockeby biomed Ltd., of Sydney, Australia, appointed David Free and Swan Jeng Tan to its board...Vaxin Inc., of Birmingham, Ala., appointed Francis Cano CEO and chairman

Neose Technologies Inc., of Horsham, Pa., promoted George Vergis to executive vice president of commercial and clinical development, Joseph Villafranca to executive vice president of pharmaceutical development and operations and David Zopf to chief scientific officer

Jan Egberts and Stephan Rechtschaffen were appointed independent directors...Neose Technologies Inc., of Horsham, Pa., appointed Ketan Desai vice president of preclinical and clinical development